An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease

NeuroImage

Volumn 60, Issue 3, 2012, Pages 1880-1889

  Fonteijn, Hubert M ^a,b   Modat, Marc ^a   Clarkson, Matthew J ^a,c   Barnes, Josephine ^c   Lehmann, Manja ^c   Hobbs, Nicola Z ^c   Scahill, Rachael I ^c   Tabrizi, Sarah J ^c,d   Ourselin, Sebastien ^a,c   Fox, Nick C ^c,d   Alexander, Daniel C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR PSYCHOLINGUISTICS   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Disease progression; Huntington's disease; MRI

Indexed keywords

ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; EVENT BASED DISEASE PROGRESSION MODEL; FAMILIAL DISEASE; HUMAN; HUNTINGTON CHOREA; IMAGING; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MEASUREMENT; PRIORITY JOURNAL; THEORY;

ALGORITHMS; ALZHEIMER DISEASE; BRAIN; COMPUTER SIMULATION; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 84857925863     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.01.062     Document Type: Article

References (37)

1. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., Johnson H.J., Magnotta V.A., Juhl A.R., Paulsen J.S. Longitudinal change in regional brain volumes in prodromal Huntington disease. J. Neurol. Neurosurg. Psychiatry 2010, 82(4):405-410.
2. Bertram L., Lill C.M., Tanzi R.E. The genetics of Alzheimer disease: back to the future. Neuron 2010, 68:270-281.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
4. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971, 31:1860-1861.
5. Cardenas V.A., Du A.T., Hardin D., Ezekiel F., Weber P., Jagust W.J., Chui H.C., Schuff N., Weiner M.W. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol. Aging 2003, 24:537-544.
6. Dempster A.P., Laird N.M., Rubin D.B. Maximum likelihood from incomplete data via the EM algorithm. J. R. Stat. Soc. B Methodol. 1977, 39:1-38.
7. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
8. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., Grodstein F., Wright C.I., Blacker D., Rosas H.D., Sperling R.A., Atri A., Growdon J.H., Hyman B.T., Morris J.C., Fischl B., Buckner R.L. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510.
9. Du A.T., Schuff N., Kramer J.H., Ganzer S., Zhu X.P., Jagust W.J., Miller B.L., Reed B.R., Mungas D., Yaffe K., Chui H.C., Weiner M.W. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 2004, 62:422-427.
10. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
11. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
12. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
13. Fonteijn H.M., Clarkson M.J., Modat M., Barnes J., Lehmann M., Ourselin S., Fox N.C., Alexander D.C. An Event-Based Disease Progression Model and Its Application to Familial Alzheimer's Disease 2011, Information Processing in Medical Imaging.
14. Gilks W.R., Richardson S., Spiegelhalter D.J. Markov Chain Monte Carlo in Practice 1996, Chapman & Hall/CRC.
15. Henley S.M., Wild E.J., Hobbs N.Z., Scahill R.I., Ridgway G.R., Macmanus D.G., Barker R.A., Fox N.C., Tabrizi S.J. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J. Neurol. 2009, 256:203-212.
16. Herrup K. Reimagining Alzheimer's disease - an age-based hypothesis. J. Neurosci. 2010, 30:16755-16762.
17. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov. Disord. 1996, 11:136-142. Huntington's Study Group.
18. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
19. Korf I. Gene finding in novel genomes. BMC Bioinformatics 2004, 5.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
21. Modat M., Ridgway G.R., Taylor Z.A., Lehmann M., Barnes J., Hawkes D.J., Fox N.C., Ourselin S. Fast free-form deformation using graphics processing units. Comput. Methods Programs Biomed. 2010, 98:278-284.
22. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C.R., Jagust W., Trojanowski J.Q., Toga A.W., Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66.
23. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., Guttman M., Johnson S., MacDonald M., Beglinger L.J., Duff K., Kayson E., Biglan K., Shoulson I., Oakes D., Hayden M. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatry 2008, 79:874-880.
24. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
25. Puolamäki K., Fortelius M., Mannila H. Seriation in paleontological data using Markov Chain Monte Carlo methods. PLoS Comput. Biol. 2006, 2:e6.
26. Rabiner L.R. A tutorial on hidden Markov-models and selected applications in speech recognition. Proc. IEEE 1989, 77:257-286.
27. Ridha B.H., Barnes J., Bartlett J.W., Godbolt A., Pepple T., Rossor M.N., Fox N.C. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 2006, 5:828-834.
28. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., Greve D., Hevelone N., Hersch S.M. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008, 131:1057-1068.
29. Scahill R.I., Schott J.M., Stevens J.M., Rossor M.N., Fox N.C. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4703-4707.
30. Shoulson I., Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979, 29:1-3.
31. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., Kennard C., Hicks S.L., Fox N.C., Scahill R.I., Borowsky B., Tobin A.J., Rosas H.D., Johnson H., Reilmann R., Landwehrmeyer B., Stout J.C. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8:791-801.
32. Tabrizi S.J., Scahill R.I., Durr A., Roos R.A., Leavitt B.R., Jones R., Landwehrmeyer G.B., Fox N.C., Johnson H., Hicks S.L., Kennard C., Craufurd D., Frost C., Langbehn D.R., Reilmann R., Stout J.C. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011, 10:31-42.
33. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
34. Thompson P.M., Mega M.S., Woods R.P., Zoumalan C.I., Lindshield C.J., Blanton R.E., Moussai J., Holmes C.J., Cummings J.L., Toga A.W. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb. Cortex 2001, 11:1-16.
35. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23:994-1005.
36. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 1985, 44:559-577.
37. Xu Y., Jack C.R., O'Brien P.C., Kokmen E., Smith G.E., Ivnik R.J., Boeve B.F., Tangalos R.G., Petersen R.C. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000, 54:1760-1767.